EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Eye Never Lies: When A Lesion Unveils Lung Cancer

Sivanesan Darshini, Nor Safiqah Sharil iD, Boon Hau Ng iD, Xin Yee Chong, Andrea Yu-Lin Ban iD, Nik Nuratiqah Nik Abeed iD

Respirology Case Reports · 2026-03 · 14 (3)

DOI: 10.1002/rcr2.70540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology Case Reports, online erschienen am 11.03.2026. Verfasst von Sivanesan Darshini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Unit, Department of Medicine, Faculty of Medicine, Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular manifestations rarely represent the first sign of systemic malignancy and often pose a diagnostic challenge. While choroidal metastases are more common, iris involvement is uncommon and may be underrecognized. Lung adenocarcinoma, particularly non‐small cell subtypes, is a known source of ocular metastases, with iris lesions occasionally preceding systemic symptoms. We report a 70‐year‐old previously healthy man presenting with one month of left eye blurred vision. Initial examination revealed conjunctival injection and visual acuity of 6/20 without detectable lesions; topical dexamethasone was prescribed. Six weeks later, vision declined to finger counting, and a hypopigmented iris mass (7.0 × 5.7 mm) was identified. A brain MRI revealed a right occipital lesion, and a CECT of the thorax, abdomen, and pelvis showed a left lung mass with bilateral nodules, mediastinal lymphadenopathy, and right iliac metastasis. CT‐guided biopsy confirmed stage IV lung adenocarcinoma (TTF‐1 and Napsin A positive, PD‐L1 TPS 80%, EGFR/ALK/ROS1 negative). Pembrolizumab was initiated; filamentous keratitis developed during therapy, and progression at three months prompted conventional chemotherapy. This case emphasizes the rarity of iris metastasis as the initial presentation of lung adenocarcinoma.

Schlagwörter

Stichwörter der Autor:innen

iris metastasislung adenocarcinomapembrolizumab

Autor:innen und Institutionen

  • Respiratory Unit, Department of Medicine, Faculty of Medicine, Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia.
  • Internal Medical Unit, Faculty of Medicine and Health Science Universiti Sains Islam Malaysia Nilai Negeri Sembilan Malaysia.
  • Ophthalmology Department Hospital Cyberjaya Selangor Malaysia.

ORCID-Profile: Nor Safiqah Sharil, Boon Hau Ng, Andrea Yu-Lin Ban, Nik Nuratiqah Nik Abeed

Zitieren

APA

Darshini, S., Sharil, N. S., Ng, B. H., Chong, X. Y., Ban, A. Y., & Abeed, N. N. N. (2026). The Eye Never Lies: When A Lesion Unveils Lung Cancer. Respirology Case Reports, 14(3). https://doi.org/10.1002/rcr2.70540

Vancouver

Darshini S, Sharil NS, Ng BH, Chong XY, Ban AY, Abeed NNN. The Eye Never Lies: When A Lesion Unveils Lung Cancer. Respirology Case Reports. 2026;14(3). doi:10.1002/rcr2.70540

BibTeX
@article{Darshini2026,
  author = {Darshini, Sivanesan and Sharil, Nor Safiqah and Ng, Boon Hau and Chong, Xin Yee and Ban, Andrea Yu-Lin and Abeed, Nik Nuratiqah Nik},
  title = {The Eye Never Lies: When A Lesion Unveils Lung Cancer},
  journal = {Respirology Case Reports},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/rcr2.70540}
}
Kostenlos starten →